Stenting strategy and imaging use in left main percutaneous coronary intervention: insights from a 15-year registry [0.03%]
左主干经皮冠状动脉介入治疗的支架植入策略及影像学应用：一项为期15年的注册研究见解
Judit Andreka,Fazila-Tun-Nesa Malik,Mariam Khandaker et al.
Judit Andreka et al.
Background: Left main (LM) percutaneous coronary intervention (PCI) remains a major interventional challenge, with outcomes influenced by various patient- and procedure-related factors. ...
Perceptions of high-sensitivity C-reactive protein testing (hsCRP) in atherosclerotic cardiovascular disease: a US survey on cardiologists and nephrologists [0.03%]
美国心脏病专家和肾病学家对动脉粥样硬化性心血管疾病中高敏C反应蛋白检测的感知：一项调查研究
Lei Lv,Ty J Gluckman,Matthew Strum et al.
Lei Lv et al.
Introduction: High-sensitivity C-reactive protein (hsCRP) is a biomarker of systemic inflammation (SI) and its elevated level is considered a risk-enhancing factor for cardiovascular disease in primary prevention. This st...
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome [0.03%]
塞meglutide：心血管-肾脏-代谢综合征管理的关键药物
Richard J MacIsaac
Richard J MacIsaac
Recent trials underscore the cardiovascular (CV), renal, and metabolic benefits of semaglutide in individuals with and without type 2 diabetes (T2D). In T2D, semaglutide enhances glycemic control, reduces major adverse CV events (MACE), and...
Favorable cardiac remodeling in response to treatment in obstructive hypertrophic cardiomyopathy: a current appraisal [0.03%]
梗阻性肥厚型心肌病治疗反应良好心脏重塑的当前评估
Susan Keen,Milind Y Desai
Susan Keen
Hypertrophic cardiomyopathy is a heterogenous genetic condition caused by myocyte disarray with varying degrees of interstitial fibrosis. Traditional management strategies focused on symptom mitigation and sudden cardiac death prevention am...
Nikita Jhawar,Shahyar Michael Gharacholou
Nikita Jhawar
Coronary kinking represents an underrecognized diagnosis which typically arises as a complication of invasive cardiovascular procedures but may also be non-iatrogenic and nonatheromatous. Determining the etiology of coronary kinking poses a...
Evolution of the management of ultrarare inherited arrhythmias and cardiomyopathies [0.03%]
超罕见遗传性心律失常和心肌病的管理进展
Saif Dababneh,Thomas M Roston
Saif Dababneh
Effect of angiotensin receptor neprilysin inhibitors in patients with STEMI: a systematic review and meta-analysis [0.03%]
血管紧张素受体脑啡肽酶抑制剂在STEMI患者中的应用效果：系统评价和meta分析
Aymen Ahmed,Muhammad Umer Sohail,Muhammad Saad et al.
Aymen Ahmed et al.
Background: ST-segment elevation myocardial infarction (STEMI) is responsible for high morbidity and mortality rates globally. Although the use of angiotensin-converting enzyme inhibitors (ACEIs) remains the cornerstone t...
Julio I Farjat-Pasos,Marisa Avvedimento,Josep Rodes-Cabau
Julio I Farjat-Pasos
Transcatheter aortic valve replacement (TAVR) represents a minimally invasive alternative for the treatment of severe symptomatic aortic stenosis and is increasingly adopted in younger and lower-risk patients. A support guidewire placed in ...
A plain language summary of the SEQUOIA-HCM study: aficamten for symptomatic obstructive hypertrophic cardiomyopathy [0.03%]
有关.aficamten治疗梗阻性肥厚型心肌病的患者层面结果总结（SEQUOIA-HCM研究）
Martin S Maron,Iacopo Olivotto,Marion van Sinttruije
Martin S Maron
Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: a meta-analysis [0.03%]
射频消融治疗肥厚型心肌病疗效和安全性的meta分析研究
Hashim Talib Hashim,Muhammad Osama,Muhammad Haris Khan et al.
Hashim Talib Hashim et al.
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic heart disease leading to obstructive hypertrophy. Radiofrequency ablation (RFA) is a minimally invasive alternative to traditional treatments. This r...